These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 32428276)

  • 1. The real-world impact of dosing of methadone and buprenorphine in retention on opioid agonist therapies in Ukraine.
    Farnum SO; Makarenko I; Madden L; Mazhnaya A; Marcus R; Prokhorova T; Bojko MJ; Rozanova J; Dvoriak S; Islam Z; Altice FL
    Addiction; 2021 Jan; 116(1):83-93. PubMed ID: 32428276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of emergency guidance to the COVID-19 pandemic on treatment entry, retention and mortality among patients on methadone in Ukraine.
    Ivasiy R; Madden LM; Meteliuk A; Machavariani E; Ahmad B; Zelenev A; Desai MM; Bromberg DJ; Polonsky M; Galvez de Leon SJ; Farnum SO; Islam Z; Altice FL
    Addiction; 2024 Sep; 119(9):1585-1596. PubMed ID: 38807448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary healthcare-based integrated care with opioid agonist treatment: First experience from Ukraine.
    Morozova O; Dvoriak S; Pykalo I; Altice FL
    Drug Alcohol Depend; 2017 Apr; 173():132-138. PubMed ID: 28242537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and factors associated with discontinuation of opioid agonist therapy among people who inject drugs in Australia.
    Geddes L; Iversen J; Wand H; Maher L
    Addiction; 2021 Mar; 116(3):525-535. PubMed ID: 32557931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent drug injection during opioid agonist treatment among people who inject drugs in Ukraine.
    Makarenko I; Mazhnaya A; Marcus R; Pykalo I; Madden L; Filippovich S; Dvoriak S; Altice FL
    J Subst Abuse Treat; 2018 Apr; 87():1-8. PubMed ID: 29471921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retention in medication-assisted treatment programs in Ukraine-Identifying factors contributing to a continuing HIV epidemic.
    Dumchev K; Dvoryak S; Chernova O; Morozova O; Altice FL
    Int J Drug Policy; 2017 Oct; 48():44-53. PubMed ID: 28800420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers to retention in methadone maintenance therapy among people who inject drugs in Bangkok, Thailand: a mixed-methods study.
    Hayashi K; Ti L; Ayutthaya PPN; Suwannawong P; Kaplan K; Small W; Kerr T
    Harm Reduct J; 2017 Sep; 14(1):63. PubMed ID: 28882155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Increased Dispensing of Opioid Agonist Therapy Take-Home Doses and Opioid Overdose and Treatment Interruption and Discontinuation.
    Gomes T; Campbell TJ; Kitchen SA; Garg R; Bozinoff N; Men S; Tadrous M; Munro C; Antoniou T; Werb D; Wyman J
    JAMA; 2022 Mar; 327(9):846-855. PubMed ID: 35230394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.
    Connock M; Juarez-Garcia A; Jowett S; Frew E; Liu Z; Taylor RJ; Fry-Smith A; Day E; Lintzeris N; Roberts T; Burls A; Taylor RS
    Health Technol Assess; 2007 Mar; 11(9):1-171, iii-iv. PubMed ID: 17313907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis.
    Socías ME; Wood E; Lake S; Nolan S; Fairbairn N; Hayashi K; Shulha HP; Liu S; Kerr T; Milloy MJ
    Addiction; 2018 Dec; 113(12):2250-2258. PubMed ID: 30238568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid Agonist Treatment and Improved Outcomes at Each Stage of the HIV Treatment Cascade in People Who Inject Drugs in Ukraine.
    Mazhnaya A; Marcus R; Bojko MJ; Zelenev A; Makarenko I; Pykalo I; Filippovych S; Dvoriak S; Altice FL
    J Acquir Immune Defic Syndr; 2018 Nov; 79(3):288-295. PubMed ID: 30312275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Testosterone and Sexual Function in Southeast Asian Men Receiving Methadone and Buprenorphine Maintenance Treatment.
    Yee A; Loh HS; Danaee M; Riahi S; Ng CG; Sulaiman AH
    J Sex Med; 2018 Feb; 15(2):159-166. PubMed ID: 29275046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Future of Opioid Agonist Therapies in Ukraine: A Qualitative Assessment of Multilevel Barriers and Ways Forward to Promote Retention in Treatment.
    Bojko MJ; Mazhnaya A; Marcus R; Makarenko I; Islam Z; Filippovych S; Dvoriak S; Altice FL
    J Subst Abuse Treat; 2016 Jul; 66():37-47. PubMed ID: 27211995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining differences in retention on medication for opioid use disorder: An analysis of Ohio Medicaid data.
    Zhang P; Tossone K; Ashmead R; Bickert T; Bailey E; Doogan NJ; Mack A; Schmidt S; Bonny AE
    J Subst Abuse Treat; 2022 May; 136():108686. PubMed ID: 34953637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of buprenorphine and methadone among opioid users who inject drugs.
    Tsui JI; Burt R; Thiede H; Glick SN
    Subst Abus; 2018 Jan; 39(1):83-88. PubMed ID: 28796591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone treatment improves tuberculosis treatment among hospitalized opioid dependent patients in Ukraine.
    Morozova O; Dvoryak S; Altice FL
    Int J Drug Policy; 2013 Nov; 24(6):e91-8. PubMed ID: 24360402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of expanding the capacity of opioid agonist treatment in Ukraine: dynamic modeling analysis.
    Morozova O; Crawford FW; Cohen T; Paltiel AD; Altice FL
    Addiction; 2020 Mar; 115(3):437-450. PubMed ID: 31478285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher methadone dose at time of release from prison predicts linkage to maintenance treatment for people with HIV and opioid use disorder transitioning to the community in Malaysia.
    Ahmad A; Bromberg DJ; Shrestha R; Salleh NM; Bazazi AR; Kamarulzaman A; Shenoi S; Altice FL
    Int J Drug Policy; 2024 Apr; 126():104369. PubMed ID: 38484531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia.
    Burns L; Gisev N; Larney S; Dobbins T; Gibson A; Kimber J; Larance B; Mattick RP; Butler T; Degenhardt L
    Addiction; 2015 Apr; 110(4):646-55. PubMed ID: 25516077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of expanding opioid agonist therapies on the HIV epidemic and mortality in Ukraine: a modelling study.
    Tan J; Altice FL; Madden LM; Zelenev A
    Lancet HIV; 2020 Feb; 7(2):e121-e128. PubMed ID: 31879250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.